A recall of cannabis vape products in Oregon is shedding light on additional non-cannabis additives that have potential to harm consumers and leading to a change in how marijuana regulators in the state operate.
The biggest development in the marijuana space this year has been a vaping-related health crisis in which hundreds of Americans have fallen ill and two dozen-plus have died from pulmonary illnesses linked to the practice.
Online marijuana advertising giant Weedmaps has offered more details on its plan to remove unlicensed cannabis retailers from its website. But a Los Angeles-area trade organization said it’s not satisfied and is calling for regulators to impose potentially billions of dollars in fines against the company and is even calling out Weedmaps in reference to the current vaping crisis.
Marijuana and hemp regulatory bodies across the United States are shortsighted in their contaminant-testing requirements for cannabis and cannabis-derived products.
The expectation is that contaminants will be identified, quantified and effectively removed from the supply chain if the contamination is significant or exceeds specification levels.
A new study of cannabis vape products from California collected during the vaping crisis of 2019 and 2020 underscored what many in the industry already know: The complexities of cannabis necessitate thorough analysis before product formulation manufacturing.
In an unprecedented move, Pennsylvania medical marijuana regulators are ordering every licensed grower/processor to resubmit vaporized cannabis products that contain additives for another approval – a move that experts fear could cause serious product disruptions and financial losses.
